🇺🇸 FDA
Pipeline program

FAT EMULSIONS , Triheptanoin

UX007-CL302

Phase 3 small_molecule active

Quick answer

FAT EMULSIONS , Triheptanoin for Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials